Fukuyama Cross-Coupling Approach to Isoprekinamycin: Discovery of the Highly Active and Bench-Stable Palladium Precatalyst POxAP.


Journal

Organic letters
ISSN: 1523-7052
Titre abrégé: Org Lett
Pays: United States
ID NLM: 100890393

Informations de publication

Date de publication:
01 02 2019
Historique:
pubmed: 19 1 2019
medline: 19 1 2019
entrez: 19 1 2019
Statut: ppublish

Résumé

An efficient and user-friendly palladium(II) precatalyst, POxAP (post-oxidative-addition precatalyst), was identified for use in Fukuyama cross-coupling reactions. Suitable for storage under air, the POxAP precatalyst allowed reaction between thioesters and organozinc reagents with turnover numbers of ∼90000. A series of 23 ketones were obtained with yields ranging from 53 to 99%. As proof of efficacy, an alternative approach was developed for the synthesis of a key precursor of the natural product isoprekinamycin.

Identifiants

pubmed: 30656941
doi: 10.1021/acs.orglett.9b00031
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

844-848

Auteurs

Shuang-Qi Tang (SQ)

Laboratoire d'Innovation Thérapeutique, Labex MEDALIS, Faculté de Pharmacie, UMR7200 CNRS , Université de Strasbourg , 74 Route du Rhin , 67412 Illkirch , France.

Jacques Bricard (J)

Laboratoire d'Innovation Thérapeutique, Labex MEDALIS, Faculté de Pharmacie, UMR7200 CNRS , Université de Strasbourg , 74 Route du Rhin , 67412 Illkirch , France.

Martine Schmitt (M)

Laboratoire d'Innovation Thérapeutique, Labex MEDALIS, Faculté de Pharmacie, UMR7200 CNRS , Université de Strasbourg , 74 Route du Rhin , 67412 Illkirch , France.

Frédéric Bihel (F)

Laboratoire d'Innovation Thérapeutique, Labex MEDALIS, Faculté de Pharmacie, UMR7200 CNRS , Université de Strasbourg , 74 Route du Rhin , 67412 Illkirch , France.

Classifications MeSH